• My Dashboard My Education Find an Ophthalmologist
  • Home
  • Coronavirus
  • For Ophthalmologists
    • Meetings
      • AAO 2022
        • Meeting Information
          • Past and Future Meetings
          • Mobile Meeting Guide
          • Contact Information
          • Annual Meeting News
          • Health and Safety
          • Policies and Disclaimers
        • Program
          • Program Highlights
          • Subspecialty Day
          • Virtual Meeting
          • Program Committees
          • CME
          • Meeting Archives
        • Expo
        • Registration
        • Hotels & Travel
          • Hotel Reservation Information
          • Chicago
          • International Attendees
          • Hotel Meeting Space
        • Presenter Central
          • Presenter Central
          • Abstract Selection Process
          • Submission Policies
          • Subject Classification/Topics
          • Instruction Courses and Skills Transfer Labs
          • Papers and Posters
          • Videos
          • Grand Rounds Symposium
          • Program Participant and Faculty Guidelines
          • Faculty Development Program
        • Exhibitors
          • Exhibitor Central
          • Exhibitor Portal Information
          • Exhibitor Prospectus
          • New Exhibiting Companies
          • Exhibitor Resources
          • International Exhibitors
          • Promotional Opportunities
          • Exhibitor Hotel Reservations
      • Mid-Year Forum
        • Registration and Travel
        • Congressional Advocacy Day
        • Advocacy Ambassador Program
        • Program
        • Schedule
        • Sponsored Attendees
        • News
      • Codequest
        • Codequest Instructors
        • Claim Codequest CME or CEU Credit
      • Eyecelerator
    • Clinical Education
      • COVID-19
      • Education
        • Browse All Education
        • Courses
        • Cases
        • Learning Plans
        • Interactive
        • Focal Points
        • Wills Eye Manual
        • Disease Reviews
        • Clinical Webinars
        • Diagnose This
        • Self-Assessments
        • Educational Centers
          • Glaucoma Education Center
          • Pediatric Ophthalmology Education Center
          • Laser Surgery Education Center
          • Myopia Resources
          • Oculofacial Plastic Surgery Center
          • Redmond Ethics Center
      • Journals
      • Guidelines
        • Browse All Practice Guidelines
        • Preferred Practice Patterns
        • Clinical Statements
        • Compendium Guidelines
        • Complementary Therapy Assessments
        • Medical Information Technology
        • Ophthalmic Technology Assessments
        • Patient Safety Statements
        • Choosing Wisely
        • Low Vision
        • Eye Care for Older Adults
        • Eye Disease Statistics
        • About the Hoskins Center
      • Video and Image Library
        • Browse All Videos
        • Clinical and Surgical Videos
        • Presentations and Lectures
        • 1-Minute Videos
        • Master Class Videos
        • Basic Skills Videos
        • Interviews
        • Images
        • Submit an Image
        • Submit a Video
      • Podcasts
        • Browse All Audio and Podcasts
        • Experts InSight
        • Ophthalmology Journal
      • News
        • Browse All Clinical News
        • Editors' Choice
        • Headlines
        • Current Insight
      • CME Central
        • Browse All CME Activities
        • Claim CME Credit and View Transcript
        • CME Planning Resources
        • Complete Your Financial Disclosure
        • Joint Sponsorship Portal
        • LEO Continuing Education Recognition Award
        • Safe ER/LA Opioid Prescribing
        • Check Your Industry Payment Records
      • MOC
      • Resident Education
        • Resident Education Home
        • Browse All Resident Content
          • Courses
          • Flashcards
          • Interactive Cases and Simulations
          • Videos
          • Webinars
        • OKAP and Board Exam Resources
          • OKAP Exam
          • Board Prep Resources
          • OKAP and Board Review Presentations
          • Study Flashcards
        • Cataract Master
        • Diversity and Inclusion Education
        • News and Advice from YO Info
        • Pediatric Ophthalmology Education Center
        • PGY-1 and PGY-2 Resources
        • Simulation in Resident Education
    • Membership
      • Join
      • Renew
      • Current Member
      • Volunteer
      • Physician Wellness
      • Member Directory
      • Member Obituaries
      • AAOE Membership
    • Advocacy
      • Advocacy News
      • Get Involved
        • Ways to Give
        • How to Get Involved
        • Congressional Advocacy
        • Support the Academy's Agenda
        • Research Legislation
        • Find Your Legislators
        • I Am an Advocate
        • Advocacy at Home
        • Advocate Tools
        • Best Practices for Advocating at Home
        • Social Media Toolkit
        • Letter to Editor
        • Town Hall Guide
        • Guide to Engaging With New Lawmakers
        • Resources
        • Attending a Political Fundraiser
      • OPHTHPAC
        • About Us
        • Join OPHTHPAC
        • OPHTHPAC Blog
      • Surgical Scope Fund
        • Support Surgery By Surgeons
        • Surgery By Surgeons Blog
    • Publications
      • EyeNet Magazine
        • Latest Issue
        • Archive
        • Subscribe
        • Advertise
        • Write For Us
        • Corporate Lunches
        • Contact
        • MIPS 2022
      • Focal Points
      • Ophthalmology
      • Ophthalmology Glaucoma
      • Ophthalmology Retina
      • YO Info
      • Scope
    • Subspecialties
      • Cataract/Anterior Segment
      • Comprehensive Ophthalmology
      • Cornea/External Disease
      • Glaucoma
      • Neuro-Ophthalmology/Orbit
      • Ocular Pathology/Oncology
      • Oculoplastics/Orbit
      • Pediatric Ophthalmology/Strabismus
      • Refractive Management/Intervention
      • Retina/Vitreous
      • Uveitis
    • IRIS Registry
      • About
      • Using the Registry
        • User Guide
        • Medicare Reporting
        • Maintenance of Certification
        • Non-EHR Reporting
      • Sign Up
        • Application Process
        • Why Participate
        • Once You've Applied: Getting Started
        • What Practices Are Saying About the Registry
      • Requirements
        • EHR Systems
        • Data & Technical Needs
      • Research
      • Registry Dashboard
      • News
      • Medicare & MIPS
    • Medicare Information
    • Diversity, Equity, and Inclusion
  • For Practice Management
    • Managing Your Practice
      • Managing Your Practice Topics
      • Coronavirus Resources
      • Reopening & Recovery
      • Practice Forms Library
      • Practice Management News and Advice
      • AAOE-Talk
      • Video Library
      • Ophthalmology Job Center
      • Benchmarking and Salary Tools
      • Academy Consultations
      • Consultant Directory
    • Coding
      • Coding Topics
      • Codequest Events
      • Ask the Coding Experts
      • Coding Updates and Resources
      • Coding for Injectable Drugs
      • EM Documentation
      • ICD-10-CM
      • Ophthalmic Coding Specialist (OCS) Exam
      • Retina
      • Savvy Coder
    • Webinars and Events
      • Annual Meeting
      • Codequest Courses
      • Mid-Year Forum
      • Webinar Recordings
    • IRIS Registry
      • Merit-Based Incentive Payment
    • Medicare and MIPS
      • MIPS
        • Quality
        • Promoting Interoperability
        • Improvement Activities
        • Cost
        • Avoid a Penalty
      • Resources
      • Medicare Participation Options
      • Medicare Advantage Plans
      • New Medicare Card
      • Provider Enrollment, Chain and Ownership System (PECOS)
    • Regulatory Compliance
      • HIPPA Resources
      • Office of Inspector General
      • Audits
      • OSHA
    • AAOE Membership
      • Join AAOE
      • Membership Benefits
      • Renew/Pay Dues
    • About AAOE
      • AAOE Board of Directors
      • AAOE Content Committee
      • Volunteer Opportunities
  • For Public & Patients
    • Eye Health A-Z
    • Symptoms
    • Glasses & Contacts
    • Tips & Prevention
    • News
    • Ask an Ophthalmologist
    • Patient Stories
    • No Cost Eye Exams
    • Español
      • A - Z de Salud Ocular
      • Síntomas
      • Anteojos y Lentes de Contacto
      • Consejos y Prevención
      • Noticias
      • Relatos de Pacientes
      • Exámenes de la vista sin costo
      • English
  • AAO 2022
    • Meeting Information
      • Past and Future Meetings
      • Mobile Meeting Guide
      • Contact Information
      • Annual Meeting News
      • Health and Safety
      • Policies and Disclaimers
    • Program
      • Program Highlights
      • Subspecialty Day
      • Virtual Meeting
      • Program Committees
      • CME
      • Meeting Archives
    • Expo
    • Registration
    • Hotels & Travel
      • Hotel Reservation Information
      • Chicago
      • International Attendees
      • Hotel Meeting Space
    • Presenter Central
      • Presenter Central
      • Abstract Selection Process
      • Submission Policies
      • Subject Classification/Topics
      • Instruction Courses and Skills Transfer Labs
      • Papers and Posters
      • Videos
      • Grand Rounds Symposium
      • Program Participant and Faculty Guidelines
      • Faculty Development Program
    • Exhibitors
      • Exhibitor Central
      • Exhibitor Portal Information
      • Exhibitor Prospectus
      • New Exhibiting Companies
      • Exhibitor Resources
      • International Exhibitors
      • Promotional Opportunities
      • Exhibitor Hotel Reservations
  • About
    • Who We Are
      • What We Do
      • About Ophthalmology
      • The Eye Care Team
      • Ethics and the Academy
      • History
      • Museum of Vision
      • Values
    • Governance
      • Council
      • Board of Trustees
      • Committees
      • Academy Past Presidents
      • Secretariats
      • Elections
      • Academy Blog
      • Academy Staff Leadership
    • Leadership Development
    • Awards
      • Laureate Recognition Award
      • Outstanding Advocate Award
      • Outstanding Humanitarian Service Award
      • International Blindness Prevention Award
      • Distinguished Service Award
      • Guests of Honor
      • Secretariat Award
      • Straatsma Award
      • Achievement Award Program
      • Artemis Award
      • EnergEYES Award
      • International Education Award
      • International Scholar Award
      • Commitment to Advocacy Award
      • Visionary Society Award
    • Financial Relationships
    • Policy Statements
    • Related Organizations
      • Subspecialty/Specialized Interest Society Directory
      • State Society Directory
      • Subspecialty/Specialized Interest Society Meetings
      • State Society Meetings
      • Resources for Societies
    • Year in Review
      • 2020 Year in Review
  • Foundation
    • About
      • 2020-2021 Annual Report
      • Annual Report Archives
      • News From the Chair
      • Foundation Staff
    • Our Impact
      • Partners for Sight
      • Donor Spotlights
      • Global Ophthalmic Community
      • Sponsorships
      • Patients and the Public
    • Giving Options
      • Our Supporters
      • Estate and Planned Giving
      • Ophthalmic Business Council
      • Parke Center Campaign
      • Minority Ophthalmology Mentoring Campaign
      • Museum of the Eye Campaign
    • Orbital Gala
      • Why Attend
      • Photo Recap
      • Corporate Support Opportunities
      • Tribute Gifts
      • Silent Auction
      • Corporate Sponsors
    • Donate
    • Museum of the Eye Campaign
      • Museum Supporters
  • Museum of the Eye
    • Visit
    • What's On
      • Museum Galleries
      • Special Exhibitions
      • Current Events
      • Past Events
    • Explore
      • Research and Resources
      • Collection Search
      • Previous Exhibits
      • Oral Histories
      • Biographies
    • Volunteer
    • Mailing List
    • Donate
    • About the Museum
      • Museum Blog
  • Young Ophthalmologists
    • YO Info
    • Learn to Bill
    • Engage with the Academy
  • Senior Ophthalmologists
    • Scope
    • Practice Transitions
  • International Ophthalmologists
    • Global Programs and Resources for National Societies
    • Awards
    • Global Outreach
  • Residents
  • Medical Students
×
Shop
Log In Create an Account
  • For Ophthalmologists
  • For Practice Management
  • For Public & Patients
  • Coronavirus
  • About
  • Foundation
  • Museum of the Eye
  • COVID-19
  • Journals
  • Education
    • Education
    • Courses
    • Cases
    • Learning Plans
    • Interactive
    • Focal Points
    • Wills Eye Manual
    • Disease Reviews
    • Clinical Webinars
    • Diagnose This
    • Self-Assessments
    • Education Centers
      • Glaucoma Education Center
      • Pediatric Ophthalmology Education Center
      • Laser Surgery Education Center
      • Oculofacial Plastic Surgery Center
      • Redmond Ethics Center
      • Myopia Resources
      • Thyroid Eye Disease Resources
  • Guidelines
    • Practice Guidelines
    • Preferred Practice Patterns
    • Clinical Statements
    • Ophthalmic Technology Assessments
    • Patient Safety Statements
    • Complementary Therapy Assessments
    • Compendium Guidelines
    • Medical Information Technology
    • Low Vision
    • Choosing Wisely
    • Eye Care for Older Adults
    • Eye Disease Statistics
    • About the Hoskins Center
    • Artificial Intelligence
    • Premium IOLs
    • Patient-Reported Outcomes with LASIK Symptoms and Satisfaction
  • Multimedia
    • Multimedia Library
    • Video
      • 1-Minute Videos
      • Presentations and Lectures
      • Master Class Videos
      • Basic Skills Videos
      • Clinical and Surgical Videos
      • Interviews
      • Resident Lectures
      • Submit a Video
      • YO Video Contest
    • Podcasts
      • Browse Podcast Archive
      • Experts InSight Podcast
      • Ophthalmology Journal Podcast
    • Images
      • Submit an Image
  • News
    • Clinical News
    • Editors' Choice
    • Headlines
    • Current Insight
  • CME
    • CME Central
    • Claim CME Credit and View Transcript
    • CME Planning Resources
    • Complete Your Financial Disclosure
    • Joint Sponsorship Portal
    • LEO Continuing Education Recognition Award
    • Safe ER/LA Opioid Prescribing
    • Check Your Industry Payment Records
  • MOC
  • Residents
    • Resident Education Home
    • Browse All Resident Content
      • Courses
      • Flashcards and Study Presentations
      • Interactive Cases and Simulations
      • Videos
      • Webinars
    • Cataract Master
    • Diversity and Inclusion Education
    • News and Advice from YO Info
    • OKAP and Board Exam Resources
      • OKAP Exam
      • Board Prep Resources
      • OKAP and Board Review Presentations
      • Study Flashcards
    • Pediatric Ophthalmology Education Center
    • PGY-1 and PGY-2 Resources
    • Resident Knowledge Exchange
    • Simulation in Resident Education
    • Clinical Education /
    • Book Excerpts /
    • Basic and Clinical Science Course - Excerpt
  • 2020–2021 BCSC Basic and Clinical Science Course™

    Go to Academy Store Learn more and Purchase.

    8 External Disease and Cornea

    Chapter 9: Infectious Diseases of the External Eye: Basic Concepts and Viral Infections

    DNA Viruses: Herpesviruses

    The structure of all herpesviruses includes a core of linear double-stranded DNA genome, surrounded by an icosahedral protein capsid, which is contained in an envelope studded with viral glycoproteins. Of the 8 known human herpesviruses, those that affect the eye include herpes simplex virus types 1 and 2 (HSV-1, HSV-2), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and Kaposi sarcoma–associated herpesvirus (KSHV). All herpesviruses establish latency in their natural hosts, but the site of latency varies. For example, whereas HSV-1, HSV-2, and VZV establish latent infections in neurons of the sensory ganglia such as the trigeminal ganglion, EBV latency occurs in B lymphocytes.

    Herpes Simplex Eye Diseases

    Herpes simplex virus infection is ubiquitous in humans; at autopsy, nearly 100% of persons older than 60 years are found to harbor HSV. Worldwide, most primary exposure to HSV occurs early in life, but in developing countries, primary exposure is increasingly delayed. It has been estimated that one-third of the world population experiences recurrent infection. HSV infections are, therefore, a large and worldwide public health problem.

    PATHOGENESIS

    HSV-1 and HSV-2 are antigenically related. HSV-1 more commonly causes infection above the waist (orofacial and ocular infection) and HSV-2, below the waist (genital infection); but either virus can cause disease in either location. Primary infection with HSV-1 frequently manifests as a nonspecific upper respiratory tract infection and is recognized as HSV less than 5% of the time. In industrialized societies, 40%–80% of adults have serum antibodies to HSV-1, which represents a decline in infection from previous decades, and the age at which individuals undergo serologic conversion is increasing; HSV is now more commonly acquired in adolescence than in childhood. HSV infection is spread by direct contact with infected lesions or their secretions, most commonly as a result of exposure to viruses shed without clinical symptoms. HSV can be transmitted to the neonate during passage through the birth canal of a mother with active genital infection. In the newborn, HSV can cause systemic infection, including encephalitis, or disease confined to the skin and mucous membranes. BCSC Section 6, Pediatric Ophthalmology and Strabismus, discusses neonatal herpes infection in greater detail.

    HSV spreads from infected skin and mucosal epithelium via sensory nerve axons to establish latent infection in associated sensory nerve ganglia, most commonly the trigeminal ganglion. Latent infection of the trigeminal ganglion may occur in the absence of recognized primary infection, and reactivation of the virus may follow in any of the 3 branches of cranial nerve V (ophthalmic nerve [V1], maxillary nerve [V2], and mandibular nerve [V3]), despite primary disease in the area of innervation of 1 particular branch. Approximately 0.15% of the US population has a history of external ocular HSV infection, and in approximately one-fifth of these individuals, stromal keratitis, the most common blinding manifestation of infection, develops.

    Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20(1): 1–13.

    Pepose JS, Keadle TL, Morrison LA. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol. 2006;141(3):547–557.

    Primary ocular infection

    CLINICAL PRESENTATION

    Primary ocular HSV infection typically manifests as a blepharoconjunctivitis. The conjunctival inflammatory response is follicular and accompanied by a palpable preauricular lymph node. Vesicles on the skin (Fig 9-2) or eyelid margin (Fig 9-3) are important for diagnosis. Patients with primary ocular HSV infection can develop epithelial keratitis (Fig 9-4), but stromal keratitis and uveitis are uncommon.

    Signs that can help the clinician distinguish acute primary ocular HSV infection from acute primary infection associated with adenovirus include the following:

    • vesicles on the skin or eyelid margin or ulcers on the bulbar conjunctiva (HSV)

    • dendritic epithelial keratitis (HSV)

    • conjunctival membranes or pseudomembranes (adenovirus)

    Laterality is not a reliable distinguishing feature. Although adenoviral infections are more commonly bilateral, they can be unilateral, bilateral but asymmetric, or bilateral with delayed involvement of the second eye. Similarly, primary HSV infection may be either unilateral (most common) or bilateral.

    Figure 9-2 Skin vesicles of herpes simplex virus (HSV) dermatoblepharitis.

    (Courtesy of James Chodosh, MD.)

    Figure 9-3 Eyelid margin ulcers characteristic of primary ocular HSV infection after vesicular rupture.

    (Courtesy of Cornea Service, Paulista School of Medicine, Federal University of São Paulo.)

    Figure 9-4 Fluorescein staining of an eye with primary HSV infection demonstrates characteristic upper eyelid margin ulcers and a coarse dendritic epithelial keratitis.

    (Courtesy of James Chodosh, MD.)

    LABORATORY EVALUATION

    Demonstration of HSV is possible in productive epithelial infection with viral culture or antigen- or DNA-detection methodologies. Results of serologic tests for neutralizing or complement-fixing immunoglobulins may show a rising antibody titer during primary infection, but these tests are of no diagnostic assistance during recurrent episodes. As most adults are latently infected with HSV, serologic testing generally is helpful only when the results are negative.

    Laboratory tests are indicated in complicated cases when the clinical diagnosis is uncertain and in all cases of suspected neonatal herpes infection. Vesicles can be opened with a needle, and vesicular fluid cultured. Scrapings from the vesicle base can be tested by cytology or for the presence of HSV antigen. Conjunctival scrapings or impression cytology specimens can be similarly analyzed by culture, antigen detection, or PCR.

    MANAGEMENT

    Primary ocular HSV infection is a self-limited condition. Oral antiviral therapy speeds resolution of signs and symptoms. Table 9-5 summarizes the antiviral agents that are effective against ocular HSV infections. For discussion about their use, see the respective clinical syndromes below.

    Recurrent ocular infection

    PATHOGENESIS

    Recurrent HSV infection is caused by reactivation of the virus in a latently infected sensory ganglion, transport of the virus down the nerve axon to sensory nerve endings, and subsequent infection of ocular surface epithelia. HSV latency locally, in the cornea, as a cause of recurrent disease remains a controversial concept.

    Table 9-5 Antiviral Agents in External/Corneal Infections With Herpes Simplex Virus

    The concept of environmental factors (psychological stress, systemic infection, sunlight exposure, menstrual cycle, and contact lens wear) acting as triggers for the recurrence of HSV ocular disease was not confirmed by the Herpetic Eye Disease Study (HEDS), despite reports of UV light–induced reactivation of herpes labialis and keratitis. HSV keratitis recurs more frequently in patients with HIV infection, but the severity of the keratitis is equal to that occurring in immunocompetent persons.

    Herpetic Eye Disease Study Group. Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Arch Ophthalmol. 2000;118(12): 1617–1625.

    CLINICAL PRESENTATION

    Recurrent HSV infection can affect almost any ocular tissue, including the eyelid, conjunctiva, cornea, iris, uveal tract, trabecular meshwork, retina, and optic nerve, and it is typically unilateral, with only 3% of patients demonstrating bilateral disease (see Table 9-7). The presence of bilateral disease should raise the possibility of immune dysfunction (eg, atopic dermatitis).

    Blepharoconjunctivitis

    Eyelid and/or conjunctival involvement can occur in patients with recurrent ocular HSV infection, although it may be clinically indistinguishable from primary infection. The condition is self-limited, but it can be treated with antiviral agents to shorten the course of illness and thus reduce the cornea’s exposure to infectious virus.

    Epithelial keratitis

    One of the most common presentations of clinically recognizable recurrent ocular HSV infection is epithelial keratitis.

    CLINICAL PRESENTATION

    Patients with epithelial keratitis report foreign-body sensation, light sensitivity, redness, and blurred vision. HSV infection of human corneal epithelium manifests as areas of punctate epithelial keratitis (Fig 9-5) that may coalesce into 1 or more arborizing dendritic epithelial ulcers whose branches have terminal bulbs. The cytopathic swollen corneal epithelium at the edge of a herpetic ulcer stains with rose bengal (Fig 9-6) or lissamine green because of loss of cell membrane glycoproteins and subsequent lack of mucin binding by the cells. The bed of the ulcer stains with fluorescein (Fig 9-7) because of loss of cellular integrity and absence of intercellular tight junctions. Areas of dendritic keratitis may coalesce further, enlarging into a more expansive geographic epithelial ulcer (Fig 9-8; see also Fig 9-7), particularly when topical corticosteroids are used.

    Figure 9-5 A, Punctate epithelial keratitis (arrows); the lesion was culture-positive for HSV. B, Note the atypical raised edges and depressed center.

    (Courtesy of Woodford S. Van Meter, MD.)

    Figure 9-6 Rose bengal staining of herpetic epithelial keratitis outlines a typical dendrite.

    (Courtesy of James Chodosh, MD.)

    Figure 9-7 Combined fluorescein and rose bengal staining of geographic HSV keratitis.

    (Courtesy of Cornea Service, Paulista School of Medicine, Federal University of São Paulo.)

    Patients with HSV epithelial keratitis exhibit a ciliary flush and mild conjunctival injection. Mild stromal edema and subepithelial white blood cell infiltration may occur beneath the epithelial keratitis. Following resolution of dendritic epithelial keratitis, non-suppurative subepithelial infiltration and scarring may be seen just beneath the area of prior epithelial ulceration, resulting in a ghost image, or ghost dendrite (Fig 9-9), which reflects the position and shape of the prior epithelial involvement.

    Focal or diffuse reduction in corneal sensation occurs following HSV epithelial keratitis. The distribution of corneal hypoesthesia is related to the extent, duration, severity, and number of recurrences of herpetic keratitis. See Chapter 4 for a more detailed description of neurotrophic keratopathy.

    Figure 9-8 Herpetic geographic epithelial keratitis.

    (Reprinted with permission from Chodosh J. Viral keratitis. In: Parrish RK, ed. The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology. Boston: Current Medicine; 1999.)

    Figure 9-9 Residual stromal inflammation following dendritic epithelial keratitis may leave the impression of a ghost image of the dendrite.

    (Reprinted with permission from Chodosh J. Viral keratitis. In: Parrish RK, ed. The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology. Boston: Current Medicine; 1999.)

    Dendritiform epithelial lesions may develop in various settings, including

    • VZV (see the discussion later in the chapter)

    • adenovirus (uncommon)

    • EBV (rare)

    • epithelial regeneration line

    • neurotrophic keratopathy (postherpetic, diabetes mellitus)

    • soft contact lens wear (due to solutions containing thimerosal)

    • topical medication use (antivirals, beta-blockers)

    • Acanthamoeba epithelial keratitis

    • epithelial deposits (eg, iron lines, Fabry disease, tyrosinemia type II, systemic drug use)

    LABORATORY EVALUATION

    A specific clinical diagnosis of HSV as the cause of dendritic keratitis can usually be made based on the presence of characteristic clinical features. Multinucleated giant cells (nonspecific) and intranuclear inclusions (more specific of herpesviruses) may be seen on corneal scrapings. Tissue culture, antigen detection techniques (ELISA), and PCR may be helpful in establishing the diagnosis in atypical cases.

    MANAGEMENT

    Most cases of HSV epithelial keratitis resolve spontaneously, and there is no clinical evidence to suggest that antiviral therapy influences the subsequent development of stromal keratitis or recurrent epithelial disease. However, treatment shortens the clinical course and might conceivably reduce the magnitude of any associated herpetic neuropathy, subepithelial scarring, or the potential risk of immune-mediated diseases of the cornea. Antiviral therapy can be used alone or in combination with epithelial debridement. Trifluridine 1% solution 8 times daily is efficacious for both dendritic and geographic epithelial keratitis. Ganciclovir 0.15% gel seems to have similar efficacy to topical acyclovir but is less toxic to the ocular surface than is trifluridine. Acyclovir 3% ophthalmic ointment has been reported to be as effective as and less toxic than trifluridine and vidarabine, but the ophthalmic form is not available in the United States at this time except through specialty compounding pharmacies. Treatment of the disease with topical antivirals generally should be discontinued within 10–14 days to avoid unnecessary toxicity to the ocular surface. Gentle epithelial debridement with a dry cotton-tipped applicator or cellulose sponge speeds resolution and may be helpful as adjunctive therapy in drug-resistant HSV keratitis.

    Oral acyclovir has been reported to be as effective as topical antivirals for the treatment of epithelial keratitis and does not cause ocular toxicity. For this reason, oral therapy is preferred by an increasing number of physicians. Valacyclovir, a prodrug of acyclovir, is just as effective for ocular HSV disease but can cause thrombotic thrombocytopenic purpura/ hemolytic uremic syndrome in severely immunocompromised patients such as those with AIDS; thus, it must be used with caution if the patient’s liver function is compromised or the immune status is unknown. Alternative systemic antiviral drugs are listed in Table 9-5.

    As previously noted, topical corticosteroids are contraindicated in the presence of active herpetic epithelial keratitis; patients with this disease who are using systemic corticosteroids for other indications should be treated aggressively with systemic antiviral therapy.

    Stromal keratitis

    HSV stromal keratitis is the most common cause of infectious corneal blindness in the United States, and it is the form of recurrent herpetic external disease associated with the greatest visual morbidity. Stromal involvement results from immunologic activity generated by the host against the virus. Each episode of active stromal keratitis increases the risk of future episodes.

    CLINICAL PRESENTATION

    Herpetic stromal keratitis can be nonnecrotizing (interstitial or disciform) or necrotizing, and different forms may present simultaneously. Herpetic interstitial keratitis presents as unifocal or multifocal interstitial haze or whitening of the stroma in the absence of epithelial ulceration (Fig 9-10). Mild stromal edema may accompany the haze, but epithelial edema is not typical. In the absence of significant extracorneal inflammatory signs such as conjunctival injection or anterior chamber cells, it may be difficult to identify active disease in an area of previous scarring and thinning. Long-standing or recurrent HSV interstitial keratitis may be associated with corneal vascularization. The differential diagnosis of herpetic interstitial keratitis includes

    Figure 9-10 Herpetic interstitial keratitis (nonnecrotizing).

    (Reprinted with permission from Chodosh J. Viral keratitis. In: Parrish RK, ed. The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology. Boston: Current Medicine; 1999.)

    • VZV keratitis

    • Acanthamoeba keratitis

    • syphilis

    • EBV keratitis

    • mumps keratitis

    • Lyme disease

    • sarcoidosis

    • Cogan syndrome

    • atopic keratitis

    • vernal keratitis

    Herpetic disciform keratitis is a primary endotheliitis, which presents as corneal stromal and epithelial edema in a round or oval distribution, associated with keratic precipitates underlying the zone of edema (Fig 9-11). Iridocyclitis can be associated, and the disciform keratitis may be confused with uveitis with secondary corneal endothelial decompensation. However, in disciform keratitis, disc-shaped stromal edema and keratic precipitates appear out of proportion to the degree of anterior chamber reaction. Disciform keratitis due to HSV and that due to VZV are clinically indistinguishable.

    Necrotizing herpetic keratitis appears as suppurative corneal inflammation (Fig 9-12). It may be severe, progress rapidly, and appear clinically indistinguishable from fulminant bacterial or fungal keratitis. Overlying epithelial ulceration is common, but the epithelial defect may occur somewhat eccentric to the infiltrate, and the edges of the epithelial ulcer do not stain with rose bengal dye. Corneal stromal vascularization is common. The differential diagnosis for necrotizing herpetic keratitis includes microbial keratitis due to bacteria, fungi, or acanthamoebae; retained foreign body; and topical anesthetic abuse.

    Figure 9-11 Herpetic disciform keratitis (nonnecrotizing).

    (Reprinted with permission from Chodosh J. Viral keratitis. In: Parrish RK, ed. The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology. Boston: Current Medicine; 1999.)

    Figure 9-12 Necrotizing herpetic stromal keratitis.

    Farooq AV, Shukla D. Corneal latency and transmission of herpes simplex virus-1. Future Virol. 2011;6(1):101–108.

    Kip KE, Cohen F, Cole SR, et al; Herpetic Eye Disease Study Group. Recall bias in a prospective cohort study of acute time-varying exposures: example from the Herpetic Eye Disease Study. J Clin Epidemiol. 2001;54(5):482–487.

    Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20(1): 1–13.

    Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976–2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol. 2010;128(9):1178–1183.

    MANAGEMENT

    Many past controversies regarding the optimal management of HSV stromal keratitis have been resolved by the landmark HEDS (Table 9-6). Most important, HEDS findings showed that topical corticosteroids given with a prophylactic antiviral reduce persistence or progression of stromal inflammation and shorten the duration of HSV stromal keratitis; in addition, long-term suppressive oral acyclovir therapy reduces the rate of recurrent HSV keratitis and helps preserve vision. Lifelong antiviral prophylaxis is recommended for patients with multiple recurrences of HSV stromal keratitis.

    The experimental protocol applied by HEDS investigators for patients with herpetic stromal keratitis is a useful starting point for a treatment algorithm. Visually significant herpetic interstitial keratitis is treated initially with prednisolone 1% drops every 2 hours, accompanied by a prophylactic antiviral drug, either topical trifluridine 4 times daily or an oral agent such as acyclovir 400 mg twice daily or valacyclovir 500 mg once a day. The prednisolone drops are tapered every 1–2 weeks depending on the degree of clinical improvement. The antiviral is given to prevent severe epithelial keratitis should the patient shed HSV while using corticosteroid drops, and it is generally continued until the patient has completely stopped the corticosteroids or is using less than 1 drop of prednisolone 1% per day. The corticosteroid should be tapered to the lowest possible dosage that controls the patient’s inflammation.

    Currently available topical antiviral medications are not absorbed by the cornea through an intact epithelium, but orally administered acyclovir penetrates an intact cornea and anterior chamber. In this context, anecdotal evidence suggests that oral acyclovir might benefit the deep corneal inflammation of disciform keratitis. The HEDS showed no additional benefit when acyclovir was added to trifluridine and prednisolone for the treatment of herpetic stromal keratitis, but disciform keratitis was not analyzed as a separate group. Some cornea specialists routinely substitute oral acyclovir for topical trifluridine in treating disciform keratitis.

    Necrotizing stromal keratitis is probably the least common but most destructive form of herpetic keratitis. The diagnosis is frequently one of exclusion following negative cultures for fungal and bacterial pathogens, but it is suggested by a history of facial, conjunctival, and/or corneal HSV infection. The toxicity of topical antiviral agents may be undesirable in patients with necrotizing inflammation and can confuse the clinical picture. Therefore, an oral antiviral such as acyclovir is preferred. Fortunately, necrotizing herpetic keratitis seems to be very sensitive to topical corticosteroids, and twice-a-day dosing may be sufficient to control inflammation in many patients.

    Iridocyclitis

    Granulomatous or nongranulomatous iridocyclitis may accompany necrotizing stromal keratitis or occur independently of corneal disease. Elevated intraocular pressure (IOP) caused by trabeculitis and/or patchy iris transillumination defects may be found in patients with HSV iridocyclitis. Viral antigen has been detected in the anterior chamber of such patients and its presence positively correlated with ocular hypertension. Therefore, the diagnosis of HSV iridocyclitis is suggested by a unilateral presentation associated with an elevated IOP with or without focal iris transillumination defects. A history or clinical evidence of prior HSV ocular disease is suggestive. One HEDS trial suggested a statistical trend toward the benefit of oral acyclovir (400 mg, 5 times daily) in treating HSV iridocyclitis in patients also receiving topical corticosteroids, but the number of patients recruited was too small to achieve statistically conclusive results.

    Table 9-6 The Herpetic Eye Disease Study

    See BCSC Section 1, Update on General Medicine, for additional discussion of viral therapeutics, and Section 2, Fundamentals and Principles of Ophthalmology, for discussion of specific antiviral agents.

    Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1871–1882.

    Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol. 1996;114(9):1065–1072.

    Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. Arch Ophthalmol. 1997;115(6):703–712.

    Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med. 1998;339(5):300–306.

    Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol. 2000;118(8): 1030–1036.

    Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12): 1883–1895.

    Complications of herpetic eye disease

    Complications of herpetic eye disease affect all layers of the cornea. Epitheliopathy is common when topical antiviral treatment is prolonged, and its severity and duration are directly related to the duration of antiviral use. Topical antiviral toxicity presents most commonly as diffuse punctate corneal epithelial erosions with conjunctival injection. Limbal stem cell deficiency may result either from recurrent infection and inflammation or from the frequent use of many of the topical antiviral drugs. Neurotrophic keratopathy may develop in patients with reduced corneal sensation secondary to previous herpetic infection. (See the section Neurotrophic Keratopathy and Persistent Corneal Epithelial Defects in Chapter 4.) Punctate epithelial erosions, sometimes with a vortex pattern of punctate fluorescein staining, chronic epithelial regeneration lines, and frank neurotrophic ulcers, characterize neurotrophic keratopathy. These ulcers can be distinguished from herpetic epithelial keratitis by a relative absence of rose bengal staining. Neurotrophic ulcers (see Chapter 4, Fig 4-1) are typically round or oval and located in the central, inferior, or inferonasal cornea. Corneal epithelium at the edges of a neurotrophic ulcer may appear to roll under itself and typically has a gray, elevated appearance. Liberal use of nonpreserved lubricating drops, gels, and ointments; autologous serum; and punctal occlusion are the mainstays of therapy. To prevent progressive stromal thinning and perforation, tarsorrhaphy and/or amniotic membrane application, either surgical or self-retaining, is indicated for neurotrophic ulcers that fail to respond to conservative therapy. On occasion, active or resolving interstitial stromal keratitis due to HSV is associated with a chronic epithelial defect that does not stain with rose bengal. This so-called metaherpetic ulcer probably results from neurotrophic mechanisms or a devitalized corneal stroma.

    Severe or long-standing disciform keratitis can result in persistent bullous keratopathy. Stromal inflammation in general, whether interstitial or necrotizing, commonly leads to permanent corneal scarring and irregular astigmatism. Both scarring and astigmatism may improve with time in some patients. Fitting with a gas-permeable contact lens usually improves vision beyond that achieved with spectacle refraction. In patients with deep corneal stromal vascularization due to prior necrotizing herpetic inflammation, secondary lipid keratopathy may further impair the vision. Topical corticosteroids may suppress new vessel growth and halt additional lipid deposition.

    Surgical treatment

    Penetrating keratoplasty (PK) or deep anterior lamellar keratoplasty (DALK) is indicated in selected patients with visually significant stromal scarring not correctable with a spectacle or contact lens. Oral antiviral therapy may improve graft survival by reducing the risk of HSV recurrence and allow more liberal use of topical corticosteroids. Oral antiviral agents are not toxic to the corneal epithelium and are therefore generally preferable to topical antivirals in patients after PK. Optical PK is successful in nearly 80% of cases when performed in eyes without signs of active inflammation for at least 6 months prior to surgery. See Chapter 15 for additional discussion of PK and DALK. Tectonic surgery is indicated in eyes with impending or frank corneal perforation due to necrotizing or neurotrophic ulcers, although stromal inflammation and ulceration may develop and graft failure may occur in inflamed herpetic eyes. Therefore, small descemetoceles and perforations in inflamed eyes may best be treated by applying therapeutic tissue adhesive and a bandage contact lens and delaying surgery until inflammation can be controlled. Amniotic membrane transplantation or conjunctival flaps may also be used for persistent epithelial defects with and without corneal thinning. Keratoprostheses may have an important role because of the risk of rejection and recurrence in HSV corneal disease.

    Excerpted from BCSC 2020-2021 series: Section 10 - Glaucoma. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.

  • Most Commented
    Loading, please wait...
    There are no comments available.
    Most Viewed
    Loading, please wait...
    Most Viewed content is not available.
  • The Academy Store
    2022-2023 Basic and Clinical Science Course, Complete Print Set
    2022-2023 Basic and Clinical Science Course, Complete eBook Set
    2022-2023 Basic and Clinical Science Course, Complete Print and eBook Set
    2022-2023 Basic and Clinical Science Course, Residency Print Set
    2022-2023 Basic and Clinical Science Course, Residency eBook Set
    2022-2023 Basic and Clinical Science Course Complete Set
    2022-2023 Basic and Clinical Science Course Residency Set
    2022-2023 Basic and Clinical Science Course, Section 01: Update on General Medicine
    2022-2023 Basic and Clinical Science Course, Section 02: Fundamentals and Principles of Ophthalmology
    2022-2023 Basic and Clinical Science Course, Section 03: Clinical Optics and Vision Rehabilitation
    2022-2023 Basic and Clinical Science Course, Section 04: Ophthalmic Pathology and Intraocular Tumors
    2022-2023 Basic and Clinical Science Course, Section 05: Neuro-Ophthalmology
    2022-2023 Basic and Clinical Science Course, Section 06: Pediatric Ophthalmology and Strabismus
    2022-2023 Basic and Clinical Science Course, Section 07: Oculofacial Plastic and Orbital Surgery
    2022-2023 Basic and Clinical Science Course, Section 08: External Disease and Cornea
    2022-2023 Basic and Clinical Science Course, Section 09: Uveitis and Ocular Inflammation
    2022-2023 Basic and Clinical Science Course, Section 10: Glaucoma
    2022-2023 Basic and Clinical Science Course, Section 11: Lens and Cataract
    2022-2023 Basic and Clinical Science Course, Section 12: Retina and Vitreous
    2022-2023 Basic and Clinical Science Course, Section 13: Refractive Surgery
    The Technician Point System: How to Improve Practice Accountability and Bottom Line (Free Member Webinar)
    Transitioning Your Practice: Retiring, Selling or Buying a Practice (Free Member Webinar)
    How to Build a Patient-First Culture (Free Member Webinar)
    2022 IRIS Registry (Intelligent Research in Sight) Preparation Kit
    Advances in Medical and Surgical Management: The 2022 Update on Glaucoma
    Presbyopia-Correcting IOLs
    2022 Codequest - Multistate (Recorded March 29)
    2022 Codequest Virtual (Multistate)
    Retina Patient Education Video Collection
    Cataract and Refractive Surgery Patient Education Video Collection
 
  • Contact Us
  • About the Academy
  • Jobs at the Academy
  • Financial Relationships with Industry
  • Medical Disclaimer
  • Privacy Policy
  • Terms of Service
  • Help
  • For Advertisers
  • For Media
  • Ophthalmology Job Center

OUR SITES

  • EyeWiki
  • International Society of Refractive Surgery

FOLLOW THE ACADEMY

Medical Professionals

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Public & Patients

  • Facebook
  • Twitter
  • Instagram
  • YouTube

Museum of the Eye

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Trip Advisor
  • Yelp
© American Academy of Ophthalmology 2022